$1.17
Today
as of Sep 4, 16:51 ET
Last 30 days
Recent Press Releases & News
Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference
Metagenomi Therapeutics (MGX) Reports Q2 Loss, Lags Revenue Estimates
Metagenomi Therapeutics: Q2 Earnings Snapshot
Overview
52-week range
$1.13
$3.95
1% of range
Avg surprise (last 3)
+3.1%
Avg reaction (last 2)
-0.5%
50% positive
Earnings trends
EPS — actual vs estimate
Actual Estimate
Revenue vs Net Income
Revenue Net income
Earnings history
| Date | Period | Actual EPS | Est | Surprise | YoY %Δ | Day react | Source |
|---|---|---|---|---|---|---|---|
| Tue Jun 30, 2026 | Jun 2026 | $-0.73 | — | — | — | — | financials |
| Mon May 11, 2026 | Mar/2026 | $-0.61 | $-0.60 | -1.7% | +10.3% | -4.3% | earnings |
| Tue Sep 30, 2025 | Sep 2025 | $-0.55 | — | — | — | — | financials |
| Tue Aug 12, 2025 | Jun/2025 | $-0.54 | $-0.68 | +20.6% | — | — | earnings |
| Tue May 13, 2025 | Mar/2025 | $-0.68 | $-0.62 | -9.7% | — | +3.2% | earnings |
| Mon Sep 30, 2024 | Sep 2024 | $-0.51 | — | — | — | — | financials |
| Sun Jun 30, 2024 | Jun 2024 | $-0.29 | — | — | — | — | financials |
| Sun Mar 31, 2024 | Mar 2024 | $-1.19 | — | — | — | — | financials |
| Sat Sep 30, 2023 | Sep 2023 | $-5.82 | — | — | — | — | financials |
| Fri Jun 30, 2023 | Jun 2023 | $-3.82 | — | — | — | — | financials |
| Fri Mar 31, 2023 | Mar 2023 | $-4.74 | — | — | — | — | financials |
Financials
Income statement (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | — | $1M | — | $9M | $9M | $4M | — | $12M |
| Cost of revenue | — | — | — | — | — | — | — | — |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $-29M | $-25M | — | $-23M | $-21M | $-28M | — | $-22M |
| Net income | $-27M | $-23M | — | $-20M | $-20M | $-25M | — | $-19M |
| EPS (diluted) | $-0.73 | $-0.61 | — | $-0.55 | $-0.54 | $-0.68 | — | $-0.51 |
Balance sheet (quarterly)
| Metric | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 | Sep 2024 |
|---|---|---|---|---|---|---|---|---|
| Cash & equivalents | $39M | $25M | $42M | $33M | $27M | $29M | $27M | $25M |
| Inventory | — | — | — | — | — | — | — | — |
| Total current assets | $124M | $145M | $166M | $190M | $212M | $233M | $258M | $282M |
| Total assets | $174M | $197M | $221M | $248M | $272M | $298M | $325M | $358M |
| Long-term debt | — | — | — | — | — | — | — | — |
| Total liabilities | $61M | $59M | $63M | $69M | $76M | $85M | $90M | $103M |
| Total equity | $113M | $138M | $159M | $178M | $196M | $213M | $235M | $256M |
Implied volatility — last 90 days
No IV snapshots yet for MGX.
IV is captured twice daily (9:15 AM & 4:30 PM ET) for tickers with upcoming earnings. Comes online automatically once the next options refresh runs.